News &amp; Updates

The novel myosin inhibitor mavacamten is well tolerated in patients with symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM) and leads to a significant decrease in N-terminal pro–B-type natriuretic peptide (NT-proBNP) and cardiac troponin I (cTnI), which suggests improvement in myocardial wall stress, a study has shown.

Mavacamten improves symptoms in nonobstructive hypertrophic cardiomyopathy

Outdoor temperature inversely tied to cardio-cerebrovascular event morbidity

The association between outdoor temperature and cardio-cerebrovascular events risk is mediated by temperature-driven blood pressure (BP), according to a study.

Outdoor temperature inversely tied to cardio-cerebrovascular event morbidity

Bioresorbable scaffolds, drug eluting stents perform comparably for long coronary lesions

Bioresorbable vascular scaffolds and everolimus-eluting stents show similar performance in patients with long native coronary artery disease, a recent study has found.

Bioresorbable scaffolds, drug eluting stents perform comparably for long coronary lesions

Blunted heart rate reserve predicts mortality in atrial fibrillation

Atrial fibrillation patients with a blunted heart rate reserve during dipyridamole stress echocardiography are at a higher risk of death, a recent study has found.

Blunted heart rate reserve predicts mortality in atrial fibrillation

More physical activity, less sedentary time may improve vascular ageing

A recent study in the general Spanish population has shown that one in 10 has healthy vascular ageing (HVA) and one in five has early vascular ageing (EVA). Increasing physical activity, reducing sedentary time, and decreasing obesity and insulin resistance improve vascular ageing.

More physical activity, less sedentary time may improve vascular ageing

Chronic pain carries heightened risk of major adverse cardiac and cerebrovascular events

Patients with chronic pain are at increased risk of developing major adverse cardiac and cerebrovascular events (MACCEs), according to a study.

Chronic pain carries heightened risk of major adverse cardiac and cerebrovascular events

Navigating the unknowns in COVID-19 the ACP way

29 May 2020 by

In the face of the COVID-19 pandemic which has taken the world by storm, the lack of approved treatments targeted towards coronavirus has left physicians worldwide grappling with the situation. To help them navigate the black box of COVID-19 management, the ACP* has released a behemoth 28-chapter guide to arm physicians in the virus-infested battle field.

Navigating the unknowns in COVID-19 the ACP way

Drinking filtered coffee may reduce mortality risk

29 May 2020 by

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

Drinking filtered coffee may reduce mortality risk

Cardiovascular risk burden tied to neurodegeneration, cognitive decline

Higher cardiovascular risk burden correlates with neurodegeneration and vascular lesions in the brain and appears to be a predictor of decline in episodic memory, working memory, and perceptual speed, a study has shown.

Cardiovascular risk burden tied to neurodegeneration, cognitive decline